drugset / Trial / NCT05116215

To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement

NCT05116215

Non-randomizedParallel-groupOpen-labelSupportive care

Summary

The supplementation of hydrogen molecules as an aid, adjuvant, may speed up recovering the course of the disease. The purpose of this study is to determine the safety and possible efficacy of hydrogen supplements in different formula and dose exposures for a clinical study in rheumatologic patients. Patients will receive a different dosage of either hydrogen capsules, hydrogen gas or hydrogen-rich water with their conventional treatment for a month. Investigators will test for any changes in haematologic, urine analysis and health status during and following the exposure period.

Timeline

Start
2021-08-13
Primary completion
2022-08-12
Completion
2022-08-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrogen Unknown 1 unknown Inhaled
Subject Hydrogen Unknown 2 % Inhaled
Subject Hydrogen Unknown 3 unknown Inhaled
Subject Hydrogen Unknown 6 unknown Inhaled
Subject Hydrogen Unknown 1000 ml Inhaled

Indications